What's in Mundipharma Pharmaceuticals B.V.'s pipeline?

Mundipharma Pharmaceuticals B.V. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mundipharma Pharmaceuticals B.V.'s portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Cari Health Inc., Cedars-Sinai Medical Center, Depomed, Norwegian University of Science and Technology.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mundipharma-pharmaceuticals-b-v.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Mundipharma Pharmaceuticals B.V. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mundipharma Pharmaceuticals B.V. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Oxycodone and naloxone	Oxycodone and naloxone	phase 3	opioid	mu-opioid receptor	Pain

Therapeutic area mix

Pain · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Cari Health Inc. · 1 shared drug class
Cedars-Sinai Medical Center · 1 shared drug class
Depomed · 1 shared drug class
Norwegian University of Science and Technology · 1 shared drug class
St. Olavs Hospital · 1 shared drug class
Talphera, Inc · 1 shared drug class
The Hospital for Sick Children · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mundipharma Pharmaceuticals B.V.:

Cite this brief

Drug Landscape (2026). Mundipharma Pharmaceuticals B.V. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mundipharma-pharmaceuticals-b-v. Accessed 2026-05-17.